We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.



Exclusive! BromoTag® Degrader for Target Exploration and Validation

Exclusive! BromoTag® Degrader for Target Exploration and Validation

BromoTag® AGB1 is our new TAG Degrader licensed exclusively to Bio-Techne by the University of Dundee. TAG Degraders are valuable tools for validating targets and use a targeted protein degradation approach that is generalizable to any intracellular target protein.

To facilitate your experiments, we also offer the negative control (BromoTag® cis-AGB1, Cat. No. 7687) and the antibody for detection of BromoTag AGB1-induced degradation of fusion proteins.

Key Features of BromoTag® AGB1

• Highly selective and potent "Bump & Hole" TAG Degrader (DC50, 6h < 15nM)
• Recruits VHL to selectively degrade proteins tagged with the mutant BromoTag domain, Brd4BD2 L387A
• Suitable for in vitro and in vivo applications

BromoTag® is a registered trademark of the University of Dundee and is used under license.

Product Specifications
Description: Potent and selective Degrader of Brd4BD2 L387A fusion proteins (BromoTag®)
Chemical Name: (S)-13-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidine-1-carbonyl)-14,14-dimethyl-11-oxo-3,6,9-trioxa-12-azapentadecyl (R)-2-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)butanoate
Purity: ≥98% (HPLC)
Molecular Weight: 1031.68
Size: 5 mg
Tag Domain Brd4BD2 L387A
Recruited E3 ligase VHL
Suitable for in vivo? Yes
Negative control available? Yes
Brd4BD2 L387A Antibody available? Yes
About Bio-Techne
Bio-Techne employs over 3,000 people globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive catalog of over 500,000 products. ?
Interested in seeing more content from Bio-Techne?
Discover all their latest news, webinars, products and more by clicking the link below.